1. Home
  2. FRSX vs KALA Comparison

FRSX vs KALA Comparison

Compare FRSX & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$0.82

Market Cap

3.4M

Sector

Technology

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.19

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSX
KALA
Founded
N/A
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.7M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
FRSX
KALA
Price
$0.82
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
71.3K
★ 503.2K
Earning Date
11-03-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 67.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$90.14
N/A
Revenue Next Year
$154.13
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.07
52 Week High
$3.00
$191.00

Technical Indicators

Market Signals
Indicator
FRSX
KALA
Relative Strength Index (RSI) 29.46 23.48
Support Level $0.78 $0.11
Resistance Level $1.47 $0.61
Average True Range (ATR) 0.08 0.04
MACD -0.01 -0.00
Stochastic Oscillator 17.50 28.49

Price Performance

Historical Comparison
FRSX
KALA

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: